Sanuwave Health, INC Form 4 insider transactions

SANUWAVE Health, Inc.'s CEO, Morgan C. Frank, reported the acquisition of 1,574 stock options, fully vested at grant, with an exercise price of $32.86.

SANUWAVE Health, Inc. Director Anthony Michael Stolarski significantly increased his direct beneficial ownership of common stock to 351,786 shares following the conversion of promissory notes and adjustments related to a 1-for-375 reverse stock split.

SANUWAVE Health's Chief Operating Officer, Peter Stegagno, reported exercising stock options and subsequently selling a portion of his common stock holdings on June 5, 2025, as detailed in a recent SEC Form 4 filing.

SANUWAVE Health, Inc. Director Gregory Matthew Bazar was granted 41,333 stock options with an exercise price of $27.97, vesting quarterly over three years.

Iulian Cioanta, Chief Science and Technology Officer of SANUWAVE Health, Inc., reports multiple transactions involving common stock and stock options on May 15, 2025.

Opaleye Management Inc. reports purchasing additional shares of SANUWAVE Health, Inc. through direct holdings and managed accounts.

James Tyler, a director of SANUWAVE Health, Inc., reports the acquisition of stock options on April 3, 2025.

Jeffrey Blizzard, a director at SANUWAVE Health, Inc., acquired stock options for 1,761 shares on April 3, 2025.

Ian D. Miller, a director of SANUWAVE Health, Inc., acquired stock options exercisable for 1,981 shares of common stock on April 3, 2025.

Morgan C. Frank, CEO of SANUWAVE Health, Inc., reports acquiring stock options on April 3, 2025.

Peter Stegagno, Chief Operating Officer of Sanuwave Health, Inc., reports exercising warrants and acquiring stock options, resulting in changes to his beneficial ownership of the company's securities.

Director Ian Miller reports transactions involving SANUWAVE Health common stock and derivative securities, including conversions of promissory notes and warrant exchanges following a reverse stock split.

Director Jeffrey Blizard reports the acquisition of stock options in SANUWAVE Health, Inc.

Director James Tyler reports transactions involving SANUWAVE Health's common stock and derivative securities, including conversions, warrant exchanges, and option grants.

SANUWAVE Health's CEO, Morgan C. Frank, received 50,000 stock options on January 31, 2025, under the company's 2024 Equity Incentive Plan.

Morgan C. Frank, CEO of SANUWAVE Health, Inc., reports acquisition of stock options under the company's 2024 Equity Incentive Plan.

Morgan C. Frank, CEO of SANUWAVE Health, Inc., reports acquisition of stock options on December 31, 2024.

Nanci Gilmore, Chief Commercial Officer of SANUWAVE Health, Inc., acquired 1,571 stock options on January 31, 2025, in lieu of a portion of her 2024 annual cash bonus.

Peter Sorensen, CFO of SANUWAVE Health, Inc., acquired stock options in lieu of a portion of his 2024 annual cash bonus on January 31, 2025.

David Timothy Wern, Executive VP of Sales at SANUWAVE Health, Inc., was granted stock options to purchase 50,000 shares of common stock.

Iulian Cioanta, Chief Science and Technology Officer at SANUWAVE Health, has acquired stock options through multiple transactions.

Opaleye Management Inc. reports increased ownership in SANUWAVE Health, Inc. through a series of open market purchases.

Timothy Hendricks, Executive VP of Sales at SANUWAVE Health, Inc., was granted stock options for 50,667 shares on October 22, 2024.

Peter Sorensen, CFO of SANUWAVE Health, Inc., reports the acquisition of stock options.

Nanci Gilmore, Chief Commercial Officer of SANUWAVE Health, Inc., reports the acquisition of stock options.

Andrew Walko, President of SANUWAVE Health, Inc., reports the acquisition of stock options.

Manchester Management and related entities report the conversion of convertible notes and warrants into common stock, along with a purchase of shares in a private placement, following a reverse stock split.

Manchester Explorer, L.P. and related parties report transactions involving warrants and convertible notes of SANUWAVE Health, Inc. following a 1-for-375 reverse stock split.

Manchester Explorer, L.P. and related parties report adjustments to their holdings of SANUWAVE Health warrants following a 1-for-375 reverse stock split.

Sanuwave Health secures $1.8 million through a private placement and promissory note, while updating stakeholders on its planned merger with SEP Acquisition Corp.